BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26440613)

  • 1. The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
    Wong DV; Lima-Júnior RC; Carvalho CB; Borges VF; Wanderley CW; Bem AX; Leite CA; Teixeira MA; Batista GL; Silva RL; Cunha TM; Brito GA; Almeida PR; Cunha FQ; Ribeiro RA
    PLoS One; 2015; 10(10):e0139985. PubMed ID: 26440613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of 5-fluorouracil activation of toll-like/MyD88/NF-κB/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic.
    Justino PFC; Franco AX; Pontier-Bres R; Monteiro CES; Barbosa ALR; Souza MHLP; Czerucka D; Soares PMG
    Cytokine; 2020 Jan; 125():154791. PubMed ID: 31401369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 deficiency upregulates TLR9 expression and enhances irinotecan-related intestinal mucositis and late-onset diarrhoea.
    Wong DVT; Holanda RBF; Cajado AG; Bandeira AM; Pereira JFB; Amorim JO; Torres CS; Ferreira LMM; Lopes MHS; Oliveira RTG; Pereira AF; Sant'Ana RO; Arruda LM; Ribeiro-Júnior HL; Pinheiro RF; Almeida PRC; Carvalho RF; Chaves FF; Rocha-Filho DR; Cunha FQ; Lima-Júnior RCP
    Br J Pharmacol; 2021 Oct; 178(20):4193-4209. PubMed ID: 34216140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
    Alvarenga EM; Souza LK; Araújo TS; Nogueira KM; Sousa FB; Araújo AR; Martins CS; Pacífico DM; de C Brito GA; Souza EP; Sousa DP; Medeiros JV
    Chem Biol Interact; 2016 Dec; 260():129-140. PubMed ID: 27838229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan decreases intestinal UDP-glucuronosyltransferase (UGT) 1A1 via TLR4/MyD88 pathway prior to the onset of diarrhea.
    Tao G; Dagher F; Li L; Singh R; Hu M; Ghose R
    Food Chem Toxicol; 2022 Aug; 166():113246. PubMed ID: 35728726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA as a Possible Ligand for TLR9 in Irinotecan-induced Small Intestinal Mucositis.
    Ávila TV; Menezes-Garcia Z; do Nascimento Arifa RD; Soriani FM; Machado AMV; Teixeira MM; Fagundes CT; Souza DG
    Immunol Invest; 2022 Aug; 51(6):1756-1771. PubMed ID: 35152824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of regulatory T cells in irinotecan-induced intestinal mucositis.
    Fernandes C; Wanderley CWS; Silva CMS; Muniz HA; Teixeira MA; Souza NRP; Cândido AGF; Falcão RB; Souza MHLP; Almeida PRC; Câmara LMC; Lima-Júnior RCP
    Eur J Pharm Sci; 2018 Mar; 115():158-166. PubMed ID: 29307857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
    Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
    Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TLR2 ligand FSL-1 and the TLR5 ligand Flagellin mediate pro-inflammatory and pro-labour response via MyD88/TRAF6/NF-κB-dependent signalling.
    Lim R; Barker G; Lappas M
    Am J Reprod Immunol; 2014 May; 71(5):401-17. PubMed ID: 24635133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
    Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.
    Roh YS; Zhang B; Loomba R; Seki E
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G30-41. PubMed ID: 25930080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin.
    Kong X; Wu SH; Zhang L; Chen XQ
    Mol Med Rep; 2015 Jul; 12(1):895-904. PubMed ID: 25760938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.
    Lima-Júnior RC; Freitas HC; Wong DV; Wanderley CW; Nunes LG; Leite LL; Miranda SP; Souza MH; Brito GA; Magalhães PJ; Teixeira MM; Cunha FQ; Ribeiro RA
    Br J Pharmacol; 2014 May; 171(9):2335-50. PubMed ID: 24428790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9.
    Gratz N; Siller M; Schaljo B; Pirzada ZA; Gattermeier I; Vojtek I; Kirschning CJ; Wagner H; Akira S; Charpentier E; Kovarik P
    J Biol Chem; 2008 Jul; 283(29):19879-87. PubMed ID: 18480050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1β and IL-18 in mice.
    Arifa RD; Madeira MF; de Paula TP; Lima RL; Tavares LD; Menezes-Garcia Z; Fagundes CT; Rachid MA; Ryffel B; Zamboni DS; Teixeira MM; Souza DG
    Am J Pathol; 2014 Jul; 184(7):2023-34. PubMed ID: 24952429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori.
    Obonyo M; Sabet M; Cole SP; Ebmeyer J; Uematsu S; Akira S; Guiney DG
    Infect Immun; 2007 May; 75(5):2408-14. PubMed ID: 17353291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation.
    Lu DX; Liu F; Wu H; Liu HX; Chen BY; Yan J; Lu Y; Sun ZG
    World J Gastroenterol; 2022 Aug; 28(32):4574-4599. PubMed ID: 36157934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
    Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
    Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.